Ethical Compliance
DIVI S LABORATORIES
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
3.7%
Debt
0%
Liquidity
25.7%
Revenue
Debt
Liquidity
3.7%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Scrap Out of Manufacturing Process | ₹3.60 |
| Export Incentives | ₹1.30 |
| Other Income | ₹3.70 |
| Sale of Services | ₹1.30 |
| Api's, Intermediates and Nutraceutical Ingredients | ₹778.20 |
Questionable
INR Crores
Non Compliant
INR Crores
| Interest Income | ₹30.10 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹30.10 |
| Total: | ₹30.10 |
| Total Revenue: | ₹818.40 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹30.10
₹818.40
= 3.7%
questionable
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
